COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,254 Articles (22,733 medRxiv, 8,521 bioRxiv)

Most recent first Previous |  Page 571: Articles 5701-5710  | Next

Effect of COVID-19 pandemic on essential health care services and mitigation strategies implemented in Benishangul gumuz: An emerging region of Ethiopia
Amaya, A. A.
10.1101/2022.11.16.22282389 — Posted: 2022-11-18
Comparative effectiveness of two- and three-dose schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study
The OpenSAFELY Collaborative, , Parker, E. P., Horne, E. M., Hulme, W. J., Tazare, J., Zheng, B., Carr, E. J., Loud, F., Lyon, S., Mahalingasivam, V., MacKenna, B., Mehrkar, A., Scanlon, M., Santhakumaran, S., Steenkamp, R., Goldacre, B., Sterne, J. A., Nitsch, D., Tomlinson, L. A., The LH&W NCS (or CONVALESCENCE) Collaborative
10.1101/2022.11.16.22282396 — Posted: 2022-11-18
Did financial interventions offset the impact of financial adversity on mental health during the COVID-19 pandemic? A longitudinal analysis of the UCL COVID-19 Social Study
Paul, E., Fancourt, D.
10.1101/2022.11.15.22282337 — Posted: 2022-11-18
Modeling analysis of COVID 19-related delays in colorectal cancer screening on simulated clinical outcomes
Miller Wilson, L.-A., Vahdat, V., Brooks, D., Limburg, P.
10.1101/2022.11.17.22282447 — Posted: 2022-11-18
STRENGTH OF ASSOCIATION BETWEEN GENERALIZED/NONSPECIFIC COVID-19 SIGNS & SYMPTOMS WITH SARS-COV 2 SPECIFIC ORF, N, E GENES IDENTIFIED THROUGH REAL TIME PCR.
Arif, M., Abdullah, M., Ahmed, S., Larik, E. A., Baloch, U. N., Hussain, Z., Baig, z. I.
10.1101/2022.11.16.22282408 — Posted: 2022-11-18
The CANDID Study: impact of COVID-19 on critical care nurses and organisational outcomes: implications for the delivery of critical care services. A questionnaire study before and during the pandemic.
McCallum, L., Rattray, J., Pollard, B., Millar, J., Hull, A., Ramsay, P., Salisbury, L., Scott, T., Cole, S., Dixon, D.
10.1101/2022.11.16.22282346 — Posted: 2022-11-18
Efficacy of the wild-type/Omicron BA.1 bivalent vaccine as the second booster dose against Omicron BA.2 and BA.5
Kawasuji, H., Morinaga, Y., Tani, H., Saga, Y., Yamada, H., Yoshida, Y., Takegoshi, Y., Kaneda, M., Murai, Y., Kimoto, K., Ueno, A., Miyajima, Y., Nagaoka, K., Ono, C., Matsuura, Y., Niimi, H., Yamamoto, Y.
10.1101/2022.11.15.22282328 — Posted: 2022-11-18
Improved Neutralization of Omicron BA.4/5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent BA.4/5 Vaccine
Zou, J., Kurhade, C., Patel, S., Kitchin, N., Tompkins, K., Cutler, M., Cooper, D., Yang, Q., Cai, H., Muik, A., Zhang, Y., Lee, D.-Y., Sahin, U., Anderson, A. S., Gruber, W. C., Xie, X., Swanson, K. A., Shi, P.-Y.
10.1101/2022.11.17.516898 — Posted: 2022-11-17
Effect of surfactants on SARS-CoV-2: Molecular Dynamics Simulations
Domingo, M., Faraudo, J.
10.1101/2022.11.17.516905 — Posted: 2022-11-17
Resistance of Omicron subvariants BA.2.75.2, BA.4.6 and BQ.1.1 to neutralizing antibodies
Planas, D., Bruel, T., Staropoli, I., Guivel-Benhassine, F., Porrot, F., Maes, P., Grzelak, L., Prot, M., Mougari, S., Planchais, C., Puech, J., Saliba, M., Sahraoui, R., Femy, F., Morel, N., Dufloo, J., Sanjuan, R., Mouquet, H., Andre, E., Hocqueloux, L., Simon-Loriere, E., Veyer, D., Prazuck, T., Pere, H., Schwartz, O.
10.1101/2022.11.17.516888 — Posted: 2022-11-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).